Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber/Boston Children’s assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a for a discussion about your care.
Can we help you find something?
Our specialized new patient coordinators can answer your questions about treatment options and becoming a patient.
President, Dana-Farber/Boston Children's Cancer and Blood Disorders Center Chairman, Pediatric Oncology, Dana-Farber Cancer Institute Associate Chief, Division of Hematology/Oncology, Boston Children’s Hospital David G. Nathan Professor of Pediatrics, Harvard Medical School
Dr. Scott A. Armstrong earned his medical degree and PhD from University of Texas Southwestern Medical School in 1996. After internship and residency training with the Boston Combined Residency Program (BCRP), he completed a hematology/oncology fellowship at Dana-Farber/Boston Children’s. Subsequently, he completed his research training here with Dr. Stanley Korsmeyer. He is a Professor of Pediatrics at Harvard Medical School. The major focus of his career has been delineating the biology of childhood cancers and the development of new therapeutic approaches for children with cancer.
David Williams, MD
Senior Vice President and Chief Scientific Officer, Boston Children's Hospital Chief, Division of Hematology/Oncology, Boston Children’s Hospital Associate Chairman, Department of Pediatric Oncology, Dana-Farber Cancer Institute Institute Physician Leland Fikes Professor of Pediatrics, Harvard Medical School
Dr. David A. Williams is a graduate of Indiana State University and Indiana University School of Medicine. After training in Pediatrics at Cincinnati Children's Hospital Medical Center, Dr. Williams completed fellowship training in Pediatric Hematology/Oncology at Dana-Farber/Boston Children's. He completed his research training here and at the Whitehead Institute at the Massachusetts Institute of Technology. He then became a faculty member at Harvard Medical School and of the Howard Hughes Medical Institute (HHMI).
Lisa Diller, MD
Vice Chair, Department of Pediatric Oncology, Dana-Farber Cancer Institute Chief Medical Officer, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center Director, David B. Perini Jr Quality of Life Clinic for Childhood Cancer Survivors, Dana-Farber Cancer Institute Institute Physician, Dana-Farber Cancer Institute Attending Physician, Division of Hematology/Oncology, Department of Pediatrics, Boston Children’s Hospital Professor of Pediatrics, Harvard Medical School
Dr. Lisa Diller is the Vice Chair, Department of Pediatric Oncology, Dana-Farber Cancer Institute, and the Chief Medical Officer, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. She is also the Director of the Perini Family Survivors Center and the David B. Perini Jr. Quality of Life Clinic at Dana-Farber Cancer Institute. She is a Professor of Pediatrics at Harvard Medical School. Dr. Diller received a bachelor's degree from Harvard University and earned her medical degree from the University of California at San Diego.
Marcie Brostoff, MS, RN, NE-BC
Vice President and Associate Chief Nurse of Nursing/Patient Care and Clinical Operations, Boston Children's Hospital
Marcie Brostoff works to transform pediatric nursing policy and practice through education and professional development as a teacher, mentor, and leader. She provides strategic and operational clinical leadership in the selection, development, deployment, reengineering, and evaluation of technology, education, and professional development of clinical staff. She serves as the Leadership Co-Chair of Boston Children’s Family Advisory Council. In partnership with the Chief Experience Officer at Boston Children’s Hospital, Marcie leads the Office of Experience. Marcie has accountability for the following practice specialties, disciplines, and programs: ANCC Magnet Program, Case Management (CM), Chaplaincy Services; Emergency Services (ED); Nursing/Patient Care for Hematology/Oncology and joint Boston Children’s and Dana-Farber Cancer Institute programs; Emergency Management; Nurse Recruitment and Retention; Patient Placement; Patient/Family Experience and Family Advisory Committees; Patient Relations and Human Rights; Physical and Occupational Therapies Services; and the Central Staffing Office.
Barbara Cuccovia, MSN, RN, CPON, BMTCN
Director of Nursing, Pediatric Oncology, Dana-Farber Cancer Institute
Barbara Cuccovia is Director of Nursing, Pediatric Oncology, at Dana-Farber Cancer Institute where she oversees the daily and clinical operations of the Jimmy Fund Clinic. She is leading an initiative to transform the nursing model in the pediatric clinic, and she serves as clinical advisor to Dana-Farber’s Pediatric Patient and Family Advisory Council. Previously, she was Nurse Manager of the Stem Cell Transplant Unit at Boston Children’s Hospital. Barbara serves on the Association of Pediatric Hematology Oncology Nursing (APHON) and is president of the local Boston APHON Chapter. She earned her bachelor’s degree in nursing from the State University of New York at Binghamton and her master’s degree in nursing, nursing leadership, and health systems management from Drexel University. She is currently pursuing her doctorate degree at the University of Massachusetts.